CV Therapeutics Offers $13.5M In Settlement Agreement
Insurers of biopharmaceutical company CV Therapeutics will pay $13.5 million to settle a federal class action lawsuit, the company revealed in a statement filed Thursday with the Securities and Exchange Commission....To view the full article, register now.
Already a subscriber? Click here to view full article